Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 studyHedy L. Kindler, Eric Van Cutsem, Jaafar Bennouna et al.|The Lancet Oncology|2011Cited by 396